EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of myeloid-derived suppressor cell (MDSC) activity by redox-modulating agents restores T and B cell proliferative responses in murine AIDS

Alessandra Fraternale, Kathy A Green, Giuditta F Schiavano, Michela Bruschi, Michele Retini, Mauro Magnani, William R Green

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Alessandra Fraternale und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, PU, Italy. Electronic address: alessandra.fraternale@uniurb.it. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, B-Lymphocytes, T-Lymphocytes, Glutathione. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università degli Studi di Urbino Carlo Bo, National Institutes of Health, Dartmouth College Geisel School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanisms by which myeloid-derived suppressor cells (MDSCs) mediate inhibition prominently include the production of reactive nitrogen species, in particular those generated by inducible nitric oxide synthase (iNOS), and reactive oxygen species. LP-BM5 murine retroviral infection results in a profound immunodeficiency, known as murine AIDS, as well as in increased numbers and activity of monocytic-type MDSCs (M-MDSCs) that suppress both T and B cell responses. While M-MDSCs suppress T cells ex vivo in a fully iNOS/NO-dependent manner, M-MDSC suppression of B cell responses is only partially due to iNOS/NO. This study preliminarily explored the role of two redox-modulating compounds in inhibiting the M-MDSC suppressive activity in LP-BM5 infection. The tested molecules were: I-152 consisting in a conjugate of N-acetyl-cysteine (NAC) and S-acetyl-cysteamine (SMEA) and C4-GSH that is the n-butanoyl glutathione (GSH) derivative. The results show that both molecules, tested in a concentration range between 3 and 20 mM, blocked the M-MDSC suppression of activated B and T cells ex vivo and restored their proliferative capacity in vivo. Ex vivo I-152 blockade of M-MDSC suppressiveness was more significant for T cell (about 70%) while M-MDSC blockade by C4-GSH was preferential for B cell responsiveness (about 60%), which was also confirmed by in vivo investigation. Beyond insights into redox-dependent suppressive effector mechanism(s) of M-MDSCs in LP-BM5 infection, these findings may ultimately be important to identify new immunotherapeutics against infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsB-LymphocytesT-LymphocytesGlutathioneAcetylcysteineMurine Acquired Immunodeficiency SyndromeAnimalsOxidation-ReductionCell ProliferationMiceLymphocyte ActivationNitric Oxide Synthase Type IIFemaleCells, Cultured

Stichwörter der Autor:innen

GlutathioneLP-BM5 infectionMDSCRedox stateRedox-modulating agents

Substanzen

GlutathioneAcetylcysteineNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, PU, Italy. Electronic address: alessandra.fraternale@uniurb.it.
  • Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, NH, United States.
  • Department of Humanities, University of Urbino Carlo Bo, Urbino, PU, Italy.
  • Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, PU, Italy.

Förderung

  • Università degli Studi di Urbino Carlo Bo
  • National Institutes of Health
  • Dartmouth College Geisel School of Medicine
  • European Commission

Zitieren

APA

Fraternale, A., Green, K. A., Schiavano, G. F., Bruschi, M., Retini, M., Magnani, M., & Green, W. R. (2023). Inhibition of myeloid-derived suppressor cell (MDSC) activity by redox-modulating agents restores T and B cell proliferative responses in murine AIDS. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110882

Vancouver

Fraternale A, Green KA, Schiavano GF, Bruschi M, Retini M, Magnani M, et al. Inhibition of myeloid-derived suppressor cell (MDSC) activity by redox-modulating agents restores T and B cell proliferative responses in murine AIDS. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110882

BibTeX
@article{Fraternale2023,
  author = {Fraternale, Alessandra and Green, Kathy A and Schiavano, Giuditta F and Bruschi, Michela and Retini, Michele and Magnani, Mauro and Green, William R},
  title = {Inhibition of myeloid-derived suppressor cell (MDSC) activity by redox-modulating agents restores T and B cell proliferative responses in murine AIDS},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110882}
}
Kostenlos starten →